Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Citrullus colocynthis fruit extract has strong antioxidant and cancer-fighting potential.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Chemotherapy toxicity might be reduced by using DNA neutralizing agents.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Boosting certain cell signals can prevent hair loss from cancer treatments.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

CRH causes hair loss by reducing cell survival in hair follicles.

Blocking autophagy worsens lipid buildup and dysfunction in brain cells after injury.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Mutant stem cells adapt their metabolism differently to outcompete normal cells in the skin.

A CCS patient with severe complications was successfully treated using combined therapies.

Quiescent cells have increased mitochondrial activity and ECM gene expression, but reduced glycolysis.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Claudin expression changes help the skin respond to injury.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Cyclosporin A is highly toxic to rats, causing severe health issues and death.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.